Thema: US92915B1061
VYGR, US92915B1061
coin-1549061_1920.jpg - Foto: THN
Voyager Therapeutics stock last traded at EUR 1.56 on October 31
Voyager Therapeutics stock was last quoted at EUR 1.56 on Saturday. The biotechnology company remains focused on gene therapy development.
ad-hoc-news.de, heute 13:45 Uhr
VYGR, US92915B1061
Voyager announces CTAD posters for Voyager Therapeutics ...
Two Alzheimer presentations are planned for November 16, 2026 and November 17, 2026. Voyager Therapeutics stock costs EUR 1.64 on October 29, 2026.
ad-hoc-news.de, 29.10.26 13:19 Uhr
VYGR, US92915B1061
Voyager names Robin Swartz president. Voyager Therapeutics ...
Two Alzheimer programs will feature posters on November 16, 2026. Voyager Therapeutics stock costs EUR 1.59 at Lang & Schwarz on October 27, 2026.
ad-hoc-news.de, 27.10.26 14:07 Uhr
VYGR, US92915B1061
Voyager names Swartz president. USD 107.2 million values ...
Robin Swartz became president on October 20, 2026. Voyager Therapeutics stock had USD 107.2 million market value after October 23, 2026 trading.
ad-hoc-news.de, 25.10.26 13:48 Uhr
VYGR, US92915B1061
HC Wainwright keeps USD 25 target for Voyager Therapeutics ...
Voyager reported USD 3.17 million revenue in the second quarter, down from USD 5.20 million. Voyager Therapeutics stock costs EUR 1.83 on October 20, 2026.
ad-hoc-news.de, 20.10.26 13:46 Uhr
VYGR, US92915B1061
Wells Fargo kept USD 10 target for Voyager Therapeutics ...
Second-quarter revenue fell to USD 3.17 million from USD 5.20 million. Voyager Therapeutics stock had a EUR 103.95 million market value on October 16, 2026.
ad-hoc-news.de, 18.10.26 12:50 Uhr
VYGR, US92915B1061
Voyager Therapeutics stock trades at EUR 1.80 as revenue ...
Second-quarter revenue was USD 3.17 million, down from USD 5.20 million. Voyager Therapeutics stock costs EUR 1.80 on October 15, 2026.
ad-hoc-news.de, 15.10.26 12:49 Uhr
VYGR, US92915B1061
Wells Fargo maintains Buy on Voyager Therapeutics stock ...
Wells Fargo's October 2, 2026 note sets a USD 10.00 target. Voyager Therapeutics stock costs EUR 2.19 versus EUR 2.18, plus 0.46 percent.
ad-hoc-news.de, 07.10.26 08:00 Uhr
VYGR, US92915B1061
Voyager Therapeutics stock gets Wells Fargo Buy rating and ...
A Wells Fargo Buy rating dated October 2, 2026, sets a USD 10.00 target for Voyager Therapeutics stock. Q2 revenue was USD 3.17 million.
ad-hoc-news.de, 06.10.26 13:04 Uhr
Voyager, Therapeutics
Voyager Therapeutics Shares Gain on Strong Quarterly Results ...
